Trademark: 90126591
Word
EYSUVIS
Status Date
Monday, April 25, 2022
Filing Date
Thursday, August 20, 2020
Published for Opposition
Tuesday, January 26, 2021
Abandoned Date
Monday, April 25, 2022
5 pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations; topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye disease
The mark consists of the stylized term EYSUVIS in dark blue. Above the "SU" is a dark blue eye shaped design with an intersecting light blue tear drop. The overlapping portion of the eye shaped design and tear drop appears in orange. The intersecting tear drop contains a reflection in white and three light blue lines extending from the design.
The color(s) dark blue, orange, light blue, and white is/are claimed as a feature of the mark.
Aug 10, 2022
Assignment Of Ownership Not Updated Automatically
Apr 25, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 25, 2022
Abandonment - No Use Statement Filed
Sep 21, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 17, 2021
Sou Extension 1 Granted
Sep 17, 2021
Sou Extension 1 Filed
Sep 17, 2021
Teas Extension Received
Mar 23, 2021
Noa E-Mailed - Sou Required From Applicant
Jan 26, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 26, 2021
Published For Opposition
Jan 6, 2021
Notification Of Notice Of Publication E-Mailed
Dec 18, 2020
Approved For Pub - Principal Register
Dec 16, 2020
Assigned To Examiner
Sep 23, 2020
Notice Of Design Search Code E-Mailed
Sep 22, 2020
New Application Office Supplied Data Entered In Tram
Aug 24, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
